Peptides for Longevity: What the Research Actually Supports
Most things sold under the "longevity" label have thin evidence at best. Longevity peptides are no different from the rest of the supplement market in that regard, and some of the claims you will find in forums and vendor copy are far ahead of what the research actually shows. This guide covers the peptides where the evidence is substantial enough to take seriously, what the evidence actually says (not what it is interpreted to say), and how they fit together into a coherent approach.
The short version: Epithalon and GHK-Cu have the strongest research bases. MOTS-c is compelling but earlier-stage. Selank and Dihexa address cognitive aging specifically. BPC-157 and TB-500 extend into structural longevity. None of these are magic. All of them are targeting specific, identifiable mechanisms of cellular aging, and that is the right framework for thinking about them.
What Makes a Peptide "Longevity" Relevant
Cellular aging proceeds through several parallel mechanisms: telomere shortening (which limits how many times a cell can divide), mitochondrial dysfunction (which reduces energy production and increases oxidative damage), accumulation of senescent cells (which secrete inflammatory signals that damage surrounding tissue), declining regenerative capacity (stem cell exhaustion), and chronic low-grade inflammation.
A longevity peptide, to be worth the label, should demonstrably affect at least one of these mechanisms. The strongest candidates address multiple mechanisms at once or act at upstream regulatory points that influence several downstream processes simultaneously.
The Compounds With Real Evidence
Epithalon Strongest human data
The anchor compound for most longevity stacks. Developed from pineal gland research by Dr. Khavinson, Epithalon is a synthetic tetrapeptide (AEDG) that activates telomerase in cell culture and has demonstrated a 28% reduction in mortality over 10 to 12 years in elderly subjects. The research is from one group and has replication limitations, but it is more human data than any other longevity peptide can claim. Sleep quality improvements from its melatonin-regulatory effects are the most immediately noticeable effect during a cycle.
Standard protocol: 5 to 10mg daily via subcutaneous injection for 10 to 20 days, 1 to 2 cycles per year.
Full Epithalon guide →GHK-Cu (Copper Peptide) Strong multi-mechanism data
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has one of the most interesting mechanistic profiles in the longevity category. It naturally declines with age, and supplementation has been shown to activate over 4,000 genes associated with tissue regeneration and suppress genes associated with cancer and inflammation. Robust evidence for skin and collagen applications. Neuroprotective effects in animal models. Antioxidant activity that directly counters oxidative telomere damage.
GHK-Cu is one of the few longevity peptides where topical application has real evidence behind it, making it accessible without injectable protocols.
Full GHK-Cu guide →MOTS-c Promising human data
MOTS-c is a mitochondrially-encoded peptide that acts as a signaling molecule between mitochondria and the nucleus. Circulating MOTS-c levels decline with age. In human studies, MOTS-c supplementation has shown improvements in insulin sensitivity and metabolic flexibility. Mitochondrial dysfunction is one of the primary hallmarks of cellular aging, and a peptide that supports mitochondrial signaling directly is mechanistically compelling.
Relatively newer compound with less long-term data than Epithalon or GHK-Cu, but the mitochondrial angle fills a gap in what the other longevity peptides address.
Full MOTS-c guide →Selank Clinical data (anxiety + neuroprotection)
Selank is a synthetic analogue of the human tuftsin protein, developed and clinically studied in Russia for anxiety and cognitive enhancement. For longevity purposes, the interest is in its neuroprotective effects and its ability to modulate BDNF (brain-derived neurotrophic factor), which declines with age and is associated with cognitive decline. Not a primary longevity compound, but a strong addition for anyone focused on cognitive aging specifically.
One of the easier-to-use longevity compounds because of its intranasal route availability alongside injectable administration.
Full Selank guide →Dihexa Animal data, limited human
Dihexa is a small peptide derived from angiotensin IV research that works through the HGF/MET signaling pathway to promote synaptogenesis, the formation of new connections between neurons. Animal research showed cognitive enhancement effects that some researchers described as orders of magnitude more potent than BDNF itself for certain memory tasks. Human data is thin. Primarily of interest for cognitive longevity applications and as a neuroprotective compound.
More speculative than the other entries on this list. Worth following as the research develops.
Full Dihexa guide →BPC-157 and TB-500 Recovery and structural longevity
These are primarily recovery peptides, but their relevance to longevity is structural: maintaining tendon, ligament, and connective tissue health as aging degrades it. Losing the ability to train effectively is one of the major mechanisms through which aging compounds. BPC-157 and TB-500 support tissue regeneration and recovery capacity, extending the functional training window. They belong in a comprehensive longevity stack for this reason, even if they are not "anti-aging" in the cellular biology sense.
TB-500 vs BPC-157 comparison →Building a Longevity Stack
A coherent longevity stack addresses aging through multiple mechanisms simultaneously rather than betting everything on one compound. The way to think about it is by mechanism layer:
A layered longevity approach
- Telomere layer: Epithalon, cycled twice yearly (5 to 10mg daily for 10 to 20 days)
- Cellular signaling layer: GHK-Cu, topical or low-dose injectable (1 to 2mg, 2 to 3x weekly)
- Mitochondrial layer: MOTS-c, run 2 to 3x weekly (0.5 to 1mg per injection)
- Cognitive layer: Selank, intranasal or injectable on training or high-demand days
- Structural layer: BPC-157 and TB-500, cycled quarterly or when recovery is declining
Most people starting with longevity peptides do not run the full stack. The typical entry point is Epithalon for one cycle to understand how the compound affects sleep and recovery, then adding GHK-Cu for ongoing use because of its broader accessibility. The full stack is for experienced users who have already characterised how each compound affects them individually.
The stack-builder quiz on the site can help identify which compounds match your specific goals. Visit the stack builder to generate a personalised protocol.
Sourcing Longevity Peptides
The longevity category has higher quality variance than mainstream peptides like BPC-157 and TB-500 because the market is smaller and testing infrastructure is less standardized among vendors. Epithalon in particular is a compound where substandard product is more common than with recovery peptides. Always verify the Certificate of Analysis from a named third-party lab before running a longevity cycle.
Vendors with consistent quality documentation across the longevity peptide category include Apollo Peptide Sciences and Amino Club. See the full 2026 vendor scorecard for current rankings and availability by compound.
The 2026 Regulatory Context
The FDA's April 2026 reclassification of several peptides, including TB-500, from Category 1 to Category 2 compounds reflects increased regulatory attention on the research peptide category broadly. GHK-Cu, MOTS-c, Selank, and Epithalon are not among the specifically targeted compounds in recent reclassifications, but the regulatory environment for the category as a whole is shifting. Sourcing from vendors with strong compliance documentation is more important now than it was 18 months ago, not less.
Common Questions
Do longevity peptides interact with each other?
The compounds covered here do not have documented negative interactions with each other. The main practical consideration when running multiple longevity peptides is injection burden and the difficulty of isolating which compound is producing which effect if you start several simultaneously. Starting one compound at a time gives you a cleaner picture of what is working.
How long before longevity peptides show results?
Sleep and recovery effects from Epithalon often appear within the first week of a cycle. GHK-Cu skin effects appear over 4 to 12 weeks. Mitochondrial and metabolic effects from MOTS-c vary. The cellular longevity effects that are the point of the category are not perceptible. They compound over years of consistent use, not over weeks. This is the honest framing for anyone entering this space.
At what age should I start longevity peptides?
The research underlying Epithalon and GHK-Cu was primarily conducted in elderly subjects. Whether the same benefit applies to younger users is unknown. Most practitioners in this space suggest that longevity interventions are most relevant from the mid-30s onward, when the markers of cellular aging begin to accumulate meaningfully. GHK-Cu, with its skin and tissue effects, is used at earlier ages specifically for its cosmetic applications.
Vendors we use for longevity compounds
See the 2026 vendor scorecard for compound-by-compound availability.
Apollo Peptide Sciences Amino Club